Rekvina Labs Ltd vs Unjha Formulations Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Rekvina Labs Ltd is ₹ 38.87 as of 18 May 16:01 . The P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Unjha Formulations Ltd changed from 37 on March 2021 to 24 on March 2025 . This represents a CAGR of -8.29% over 5 years The Market Cap of Rekvina Labs Ltd changed from ₹ 2.39 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Unjha Formulations Ltd changed from ₹ 3.81 crore on March 2021 to ₹ 9.78 crore on March 2025 . This represents a CAGR of 20.75% over 5 years The revenue of Rekvina Labs Ltd for the Dec '25 is ₹ 0.35 crore as compare to the Sep '25 revenue of ₹ 0.2 crore. This represent the growth of 75% The revenue of Unjha Formulations Ltd for the Dec '25 is ₹ 4.44 crore as compare to the Sep '25 revenue of ₹ 4.35 crore. This represent the growth of 2.07% The ebitda of Rekvina Labs Ltd for the Dec '25 is ₹ -0.12 crore as compare to the Sep '25 ebitda of ₹ -0.03 crore. This represent the growth of 300% The ebitda of Unjha Formulations Ltd for the Dec '25 is ₹ 0.28 crore as compare to the Sep '25 ebitda of ₹ 0.85 crore. This represent the decline of -67.06% The net profit of Rekvina Labs Ltd changed from ₹ -0.07 crore to ₹ -0.12 crore over 6 quarters. This represents a CAGR of 43.24% The net profit of Unjha Formulations Ltd changed from ₹ 0.7 crore to ₹ 0.24 crore over 7 quarters. This represents a CAGR of -45.76% The Dividend Payout of Rekvina Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Unjha Formulations Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Rekvina Labs Ltd

Rekvina Labs Limited was incorporated on 1st November 1988.
From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore.
It is registered in England and Wales as a Public Limited Company.
The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements.
It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products.

About Unjha Formulations Ltd

Unjha Formulations Limited was established in June, 1987 as a Partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
The Company is a pioneer in Isabgol (Psyllium) Formulation.
The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
It is one of the largest manufacturers of isabgul products in India.
The company's products are classified under two divisions -- human consumption and veterinary products. Its parent company M/S Urvesh Ltd. is 100% EOU is engaged in exporting of Isabol Husk & Isabgol Powder.

FAQs for the comparison of Rekvina Labs Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Rekvina Labs Ltd or Unjha Formulations Ltd?

Market cap of Rekvina Labs Ltd is 24 Cr while Market cap of Unjha Formulations Ltd is 9 Cr

What are the key factors driving the stock performance of Rekvina Labs Ltd and Unjha Formulations Ltd?

The stock performance of Rekvina Labs Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rekvina Labs Ltd and Unjha Formulations Ltd?

As of May 18, 2026, the Rekvina Labs Ltd stock price is INR ₹40.91. On the other hand, Unjha Formulations Ltd stock price is INR ₹20.11.

How do dividend payouts of Rekvina Labs Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Rekvina Labs Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.